. | . |
China approves world's first inhalable Covid-19 vaccine by AFP Staff Writers Beijing (AFP) Sept 5, 2022 Chinese drug regulators have approved the world's first inhalable Covid-19 vaccine, made by Tianjin-based manufacturer CanSino Biologics, boosting the company's share price by seven percent on Monday. The National Medical Products Administration gave the go-ahead for the vaccine for emergency use as a booster, the company said in a statement to the Hong Kong Stock Exchange on Sunday. Following the announcement, company shares surged 14 percent on Monday morning before closing 7.1 percent higher than their opening value. The needle-free vaccine -- which can be stored and administered more easily than intramuscular jabs -- will be given through a nebuliser, the company said. "The approval will have a positive impact on the company's performance if the vaccine is subsequently purchased and used by relevant government agencies," the statement added. The company did not offer details on when the adenovirus-vectored vaccine will be made available for public use. There is no publicly available verified or peer-reviewed data on the efficacy of the new vaccine. Scientists in several countries including Cuba, Canada and the United States are also trialling inhalable Covid-19 vaccines. China has so far approved eight other locally manufactured injectable vaccines since 2020. But the country's drug administrator is yet to greenlight any foreign vaccines, including mRNA shots produced by Pfizer/BioNTech or Moderna that have better efficacy rates compared to other types of vaccines. China is the only major economy sticking to a zero-Covid policy, disrupting travel and businesses. Officials across the country are now under pressure to curb local virus flare-ups ahead of a key political meeting next month. The southern tech hub of Shenzhen, with more than 18 million residents, imposed a weekend lockdown in most parts of the city on Saturday, while more than 21 million people in the southwestern metropolis of Chengdu are undergoing mass testing from Monday through Wednesday. China has administered over 3.4 billion Covid shots, the National Health Commission said Monday without offering details on the percentage of the population vaccinated. prw/je/aha
Millions locked down in China's Chengdu over Covid outbreak Beijing (AFP) Sept 2, 2022 Millions were stuck at home in China's Chengdu on Friday after a handful of Covid-19 cases brought the megacity to a standstill. Supermarket shelves were stripped bare this week as locals in the city - a powerhouse economic hub in China's southwest that is home to 21 million people - feared a repeat of the months-long lockdown in the eastern megalopolis of Shanghai earlier this year. Long lines of residents queued for mandatory testing, while videos verified by AFP showed supermarket shelves c ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |